Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""modified vaccinia virus Ankara"" wg kryterium: Temat


Wyświetlanie 1-8 z 8
Tytuł:
Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein.
Autorzy:
Daian E Silva DSO; Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, MG, CEP 31270-901, Brazil.; GIPH - Grupo Interdisciplinar de Pesquisas em HTLV, Interdisciplinary HTLV Research Group, Belo Horizonte, Brazil.
Cox LJ; Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, MG, CEP 31270-901, Brazil.; GIPH - Grupo Interdisciplinar de Pesquisas em HTLV, Interdisciplinary HTLV Research Group, Belo Horizonte, Brazil.
Rocha AS; Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, MG, CEP 31270-901, Brazil.; GIPH - Grupo Interdisciplinar de Pesquisas em HTLV, Interdisciplinary HTLV Research Group, Belo Horizonte, Brazil.
Lopes-Ribeiro Á; Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, MG, CEP 31270-901, Brazil.
Souza JPC; Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, 31270-901, Brazil.
Franco GM; Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, MG, CEP 31270-901, Brazil.; GIPH - Grupo Interdisciplinar de Pesquisas em HTLV, Interdisciplinary HTLV Research Group, Belo Horizonte, Brazil.
Prado JLC; Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, MG, CEP 31270-901, Brazil.
Pereira-Santos TA; Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, MG, CEP 31270-901, Brazil.; GIPH - Grupo Interdisciplinar de Pesquisas em HTLV, Interdisciplinary HTLV Research Group, Belo Horizonte, Brazil.
Martins ML; GIPH - Grupo Interdisciplinar de Pesquisas em HTLV, Interdisciplinary HTLV Research Group, Belo Horizonte, Brazil.; Gerência de Desenvolvimento Técnico Científico, Fundação Centro de Hematologia e Hemoterapia do Estado de Minas Gerais - Hemominas, Belo Horizonte, Brazil.
Coelho-Dos-Reis JGA; Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, MG, CEP 31270-901, Brazil.; GIPH - Grupo Interdisciplinar de Pesquisas em HTLV, Interdisciplinary HTLV Research Group, Belo Horizonte, Brazil.
Gomes-de-Pinho TM; Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, 31270-901, Brazil.
Da Fonseca FG; Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, MG, CEP 31270-901, Brazil.; Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, 31270-901, Brazil.
Barbosa-Stancioli EF; Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, MG, CEP 31270-901, Brazil. .; GIPH - Grupo Interdisciplinar de Pesquisas em HTLV, Interdisciplinary HTLV Research Group, Belo Horizonte, Brazil. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2023 Dec 19; Vol. 20 (1), pp. 304. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
Human T-lymphotropic virus 1*
Vaccines, DNA*/genetics
Mice ; Humans ; Animals ; CD8-Positive T-Lymphocytes ; Granzymes/genetics ; Tumor Necrosis Factor-alpha ; Viral Proteins/metabolism ; Vaccinia virus/genetics ; DNA ; Basic-Leucine Zipper Transcription Factors ; Retroviridae Proteins/genetics
Czasopismo naukowe
Tytuł:
Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice.
Autorzy:
Kalodimou G; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, 85764 Oberschleißheim, Germany.
Jany S; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.
Freudenstein A; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.
Schwarz JH; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.
Limpinsel L; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.
Rohde C; Institute of Virology, Philipps University of Marburg, 35043 Marburg, Germany.; German Center for Infection Research (DZIF), Partner Site Gießen-Marburg-Langen, 35043 Marburg, Germany.
Kupke A; Institute of Virology, Philipps University of Marburg, 35043 Marburg, Germany.; German Center for Infection Research (DZIF), Partner Site Gießen-Marburg-Langen, 35043 Marburg, Germany.
Becker S; Institute of Virology, Philipps University of Marburg, 35043 Marburg, Germany.; German Center for Infection Research (DZIF), Partner Site Gießen-Marburg-Langen, 35043 Marburg, Germany.
Volz A; Institute of Virology, University of Veterinary Medicine Hannover, 30559 Hannover, Germany.; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30559 Hannover, Germany.
Tscherne A; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, 85764 Oberschleißheim, Germany.
Sutter G; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, 85764 Oberschleißheim, Germany.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 May 17; Vol. 15 (5). Date of Electronic Publication: 2023 May 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
SARS-CoV-2*
COVID-19*/prevention & control
Humans ; Animals ; Mice ; Pandemics ; Vaccinia virus ; Vaccination/methods ; Antibodies, Viral ; Immunity, Cellular ; Immunity, Humoral
SCR Organism:
Modified Vaccinia Ankara virus
Czasopismo naukowe
Tytuł:
Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses.
Autorzy:
Mytle N; Emergent BioSolutions, 300 Professional Drive, Gaithersburg, MD 20879, USA.; Biomedical Advanced Research and Development Agency, U.S. Department of Health and Human Services, Washington, DC 20201, USA.
Leyrer S; Emergent BioSolutions, 300 Professional Drive, Gaithersburg, MD 20879, USA.; Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany.
Inglefield JR; Emergent BioSolutions, 300 Professional Drive, Gaithersburg, MD 20879, USA.; Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Harris AM; Emergent BioSolutions, 300 Professional Drive, Gaithersburg, MD 20879, USA.
Hickey TE; Emergent BioSolutions, 300 Professional Drive, Gaithersburg, MD 20879, USA.; National Cancer Institute, National Institutes of Health, Frederick, MD 20814, USA.
Minang J; Emergent BioSolutions, 300 Professional Drive, Gaithersburg, MD 20879, USA.; Optimal Health Care, 11377 Robinwood Dr, Hagerstown, MD 21742, USA.
Lu H; Emergent BioSolutions, 300 Professional Drive, Gaithersburg, MD 20879, USA.
Ma Z; Emergent BioSolutions, 300 Professional Drive, Gaithersburg, MD 20879, USA.
Andersen H; BIOQUAL, Inc., 12301 Parklawn Dr, Rockville, MD 20852, USA.
Grubaugh ND; Emergent BioSolutions, 300 Professional Drive, Gaithersburg, MD 20879, USA.; Yale School of Public Health, Yale University, 60 College Street, New Haven, CT 06510, USA.
Guina T; Emergent BioSolutions, 300 Professional Drive, Gaithersburg, MD 20879, USA.; AstraZeneca, Gaithersburg, MD 20878, USA.
Skiadopoulos MH; Emergent BioSolutions, 300 Professional Drive, Gaithersburg, MD 20879, USA.; U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD 20892, USA.
Lacy MJ; Emergent BioSolutions, 300 Professional Drive, Gaithersburg, MD 20879, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Aug 27; Vol. 13 (9). Date of Electronic Publication: 2021 Aug 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Viral/*blood
Influenza A Virus, H1N1 Subtype/*immunology
Influenza A Virus, H5N1 Subtype/*immunology
Influenza Vaccines/*immunology
Nucleocapsid Proteins/*immunology
Orthomyxoviridae Infections/*prevention & control
Viral Matrix Proteins/*immunology
Viroporin Proteins/*immunology
Animals ; Antigens, Viral/immunology ; Cross Protection ; Female ; Genetic Vectors ; Influenza A Virus, H1N1 Subtype/pathogenicity ; Influenza A Virus, H5N1 Subtype/pathogenicity ; Influenza Vaccines/administration & dosage ; Mice, Inbred BALB C ; Nucleocapsid Proteins/administration & dosage ; Orthomyxoviridae Infections/immunology ; Pandemics ; Vaccination ; Viral Matrix Proteins/administration & dosage ; Viral Matrix Proteins/genetics ; Viroporin Proteins/administration & dosage
Czasopismo naukowe
Tytuł:
Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccines Efficiently Protect Cockatiels Against Parrot Bornavirus Infection and Proventricular Dilatation Disease.
Autorzy:
Rall I; Institute of Virology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Hermann-Herder-Str. 11, D-79104 Freiburg, Germany.; Department of Immunology, Interfaculty Institute of Cell Biology, Eberhard Karls Universität Tübingen, Auf der Morgenstelle 15, D-72076 Tübingen, Germany.
Amann R; Department of Immunology, Interfaculty Institute of Cell Biology, Eberhard Karls Universität Tübingen, Auf der Morgenstelle 15, D-72076 Tübingen, Germany.
Malberg S; Institute for Veterinary Pathology, University Justus Liebig Gießen, Frankfurter Str. 96, D-35392 Gießen, Germany.
Herden C; Institute for Veterinary Pathology, University Justus Liebig Gießen, Frankfurter Str. 96, D-35392 Gießen, Germany.
Rubbenstroth D; Institute of Virology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Hermann-Herder-Str. 11, D-79104 Freiburg, Germany.; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, D-17493 Greifswald-Insel Riems, Germany.
Pokaż więcej
Źródło:
Viruses [Viruses] 2019 Dec 06; Vol. 11 (12). Date of Electronic Publication: 2019 Dec 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bird Diseases/*prevention & control
Bird Diseases/*virology
Bornaviridae/*immunology
Mononegavirales Infections/*veterinary
Vaccinia virus/*immunology
Viral Vaccines/*immunology
Animals ; Bird Diseases/diagnosis ; Cockatoos ; Immunization ; Parrots ; RNA, Viral ; Viral Proteins/immunology
Czasopismo naukowe
Tytuł:
CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.
Autorzy:
Okoli A; Biosafety of Genome Editing Research Group, GenØk-Centre for Biosafety, Siva Innovation Centre, N-9294 Tromsø, Norway. .
Okeke MI; Biosafety of Genome Editing Research Group, GenØk-Centre for Biosafety, Siva Innovation Centre, N-9294 Tromsø, Norway. .
Tryland M; Biosafety of Genome Editing Research Group, GenØk-Centre for Biosafety, Siva Innovation Centre, N-9294 Tromsø, Norway. .; Artic Infection Biology, Department of Artic and Marine Biology, The Artic University of Norway, N-9037 Tromsø, Norway. .
Moens U; Molecular Inflammation Research Group, Institute of Medical Biology, The Arctic University of Norway, N-9037 Tromsø, Norway. .
Pokaż więcej
Źródło:
Viruses [Viruses] 2018 Jan 22; Vol. 10 (1). Date of Electronic Publication: 2018 Jan 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
CRISPR-Cas Systems*
Gene Editing*
Genetic Vectors*
Genome, Viral*
Viral Vaccines*
Orthopoxvirus/*genetics
Animals ; Endodeoxyribonucleases/genetics ; Endonucleases/genetics ; Humans ; Transcription Activator-Like Effector Nucleases/genetics
Czasopismo naukowe
Tytuł:
Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
Autorzy:
Okeke MI; Genome Editing Research Group, GenØk-Center for Biosafety, Siva Innovation Center, N-9294 Tromso, Norway. .
Okoli AS; Genome Editing Research Group, GenØk-Center for Biosafety, Siva Innovation Center, N-9294 Tromso, Norway. .
Diaz D; Molecular Inflammation Research Group, Institute of Medical Biology, University i Tromsø (UiT)-The Arctic University of Norway, N-9037 Tromso, Norway. .
Offor C; Department of Medical and Pharmaceutical Biotechnology, IMC University of Applied Sciences Piaristengasse 1, A-3500 Krems, Austria. .
Oludotun TG; Department of Medical and Pharmaceutical Biotechnology, IMC University of Applied Sciences Piaristengasse 1, A-3500 Krems, Austria. .
Tryland M; Genome Editing Research Group, GenØk-Center for Biosafety, Siva Innovation Center, N-9294 Tromso, Norway. .; Artic Infection Biology, Department of Artic and Marine Biology, UIT-The Artic University of Norway, N-9037 Tromso, Norway. .
Bøhn T; Genome Editing Research Group, GenØk-Center for Biosafety, Siva Innovation Center, N-9294 Tromso, Norway. .
Moens U; Molecular Inflammation Research Group, Institute of Medical Biology, University i Tromsø (UiT)-The Arctic University of Norway, N-9037 Tromso, Norway. .
Pokaż więcej
Źródło:
Viruses [Viruses] 2017 Oct 29; Vol. 9 (11). Date of Electronic Publication: 2017 Oct 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Genetic Vectors*
Vaccines, Synthetic/*adverse effects
Vaccinia virus/*genetics
Animals ; Containment of Biohazards ; Environment ; Humans ; Risk Assessment ; Vaccination ; Vaccinia virus/immunology
Czasopismo naukowe
Tytuł:
Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA).
Autorzy:
Eggers M; Labor Prof. Gisela Enders MVZ GbR and the Institute of Virology, Infectious Diseases and Epidemiology e.V., Stuttgart, Germany.
Eickmann M; Institute for Virology, Philipps University of Marburg, Marburg, Germany.
Zorn J; Mundipharma Research GmbH & Co.KG, Limburg, Germany. .
Pokaż więcej
Źródło:
Infectious diseases and therapy [Infect Dis Ther] 2015 Dec; Vol. 4 (4), pp. 491-501. Date of Electronic Publication: 2015 Sep 28.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies